Riskpilot← Back to searchSign inGet full accessNäsets Hälsoklinik AB
ABActiveOrg 5592558943Västra Fasanvägen 25Other personal service activities n.e.c. · NACE 9699Est. 20200 employees
Revenue 2025
SEK 1,6M
+47% vs 2024
EBITDA margin
6.6%
-82% vs 2024
Equity ratio
58.0%
Financial strength
Net profit 2025
SEK 43K
-87% vs 2024
| Revenue | SEK 1,6M | +47% |
| EBITDA | SEK 106K | -82% |
| Net profit | SEK 43K | -87% |
| Total assets | SEK 1,1M | +6% |
| Equity | SEK 653K | +7% |
| Employees | 0 | — |
Legal name
Näsets Hälsoklinik AB
Org number
5592558943
Legal form
Aktiebolag
NACE code
9699 · Other personal service activities n.e.c.
Founded
14 maj 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-07-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att utföra coachning, samtal och handledning inom hälsa- och friskvård. Vidare bedriver bolaget konsultuppdrag, utbildning och informationsverksamhet inom hälsa och sjukvård. Verksamheten riktar sig till enskilda personer, företag och kommuner samt landsting.
Address
Västra Fasanvägen 25
Email
ann.claughtonwallin@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 55 | 330 | 253 | 1 096 | 1 611 |
| Staff expenses | — | −0 | −9 | −8 | −45 |
| EBITDA | 3 | 265 | 158 | 582 | 106 |
| Depreciation & amort. | −0 | — | — | −30 | −30 |
| EBIT | 3 | 265 | 158 | 552 | 76 |
| Net financials | — | −0 | −2 | −1 | −1 |
| Profit before tax | 3 | 200 | 116 | 420 | 55 |
| Tax | −1 | −41 | −25 | −87 | −13 |
| Net profit | 2 | 158 | 92 | 333 | 43 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 30 | 371 | 504 | 1 060 | 1 126 |
| Equity | 27 | 186 | 277 | 610 | 653 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 2 | 120 | 122 | 215 | 219 |
| Total debt | 2 | 120 | 122 | 215 | 219 |
EBITDA margin
6.6%
This company
15.8%
Market median
-58% vs market
20212025
Equity ratio
58.0%
This company
38.2%
Market median
+52% vs market
20212025
Return on equity
6.5%
This company
18.4%
Market median
-65% vs market
20212025
Net profit margin
2.6%
This company
8.1%
Market median
-68% vs market
20212025
Asset turnover
1.43×
This company
1.12×
Market median
+28% vs market
20212025
Debt / equity
0.73×
This company
0.62×
Market median
+18% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-08-01 – 2025-07-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-08-01 – 2024-07-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-08-01 – 2023-07-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-08-01 – 2022-07-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-07-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Näsets Hälsoklinik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ann Margareta Claughton-Wallin | Board of Directors | 0 companies |
| Carl Eric Christian Claughton-Wallin | Deputy Board Member | 0 companies |